Frequency News and Research

RSS

Proteus receives U.S. patent entitled, 'Body Associated Receiver and Method'

Proteus Biomedical Inc., a pioneer in digital health, announced today that the United States Patent Office will award U.S. Patent Number 8114021 to Proteus. The patent, entitled "Body Associated Receiver and Method," is directed to the Proteus wearable and ingestible sensor technologies and related sensor devices used to create digital communication networks within, on and around the human body for health-related and other applications.

31 Jan 2012

Modern ultrasound for male contraception

The ideal male contraceptive would be inexpensive, reliable, and reversible. It would need to be long acting but have few side effects. New research published in BioMed Central's open access journal Reproductive Biology and Endocrinology used commercially available therapeutic ultrasound equipment to reduce sperm counts of male rats to levels which would result in infertility in humans.

30 Jan 2012

Study investigates how bacteria change their disguise to evade vaccines

Genetics has provided surprising insights into why vaccines used in both the UK and US to combat serious childhood infections can eventually fail. The study, published today in Nature Genetics, which investigates how bacteria change their disguise to evade the vaccines, has implications for how future vaccines can be made more effective.

30 Jan 2012

First evidence links cancer to mutations in genes involved in DNA organization

St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project provides first evidence linking cancer to mutations in genes involved in DNA organization

30 Jan 2012

Diabetes may cause women to experience hearing loss as they age

Having diabetes may cause women to experience a greater degree of hearing loss as they age, especially if the metabolic disorder is not well controlled with medication, according to a new study from Henry Ford Hospital in Detroit.

27 Jan 2012

FDA approves UCB's Keppra for treatment of partial onset seizures in infants

UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Keppra (levetiracetam) tablets and oral solution as adjunctive therapy in the treatment of partial onset seizures in adults and children one month of age and older with epilepsy.

27 Jan 2012

Multiple sclerosis drug Gilenya under investigation by FDA and EMA

The US Food and Drugs Administration (FDA) and European Medicines Agency (EMA) are looking at the pros and cons of using Gilenya (fingolimod) in treating the neurological autoimmune disease Multiple Sclerosis (MS).

23 Jan 2012

Ambiguity makes language more efficient

Why did language evolve? While the answer might seem obvious - as a way for individuals to exchange information - linguists and other students of communication have debated this question for years. Many prominent linguists, including MIT's Noam Chomsky, have argued that language is, in fact, poorly designed for communication.

20 Jan 2012

Study examines drug resistance in ALK positive lung cancer

Scientists from the University of Colorado Cancer Center have once again advanced the treatment of a specific kind of lung cancer. The team has documented how anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC) becomes resistant to a drug targeting the abnormal protein in the cancer. It's the first time scientists have analyzed the frequency and type of drug resistance in ALK positive patients taking crizotinib.

19 Jan 2012

Vitamin D could prevent age related eye degeneration: Study

A new study showed that increased vitamin D intake can help to prevent age-related diseases, in particular loss of vision and blindness.

18 Jan 2012

VeriTeQ acquires PositiveID's VeriChip and Health Link web-based PHR

VeriTeQ Acquisition Corporation, a marketer of implantable, radio frequency identification technologies for patient identification and sensor applications, announced today it has acquired the VeriChip implantable microchip and related technologies, and Health Link personal health record from PositiveID Corporation.

18 Jan 2012

Chronology of Fetal Alcohol Syndrome revealed

It is known from studies that exposure to alcohol during gestation can cause a range of birth defects. But now scientists have drawn up a chronology of when the damage occurs.

17 Jan 2012

Study examines quantity, frequency and timing of alcohol consumption during pregnancy

Prenatal exposure to alcohol is associated with a spectrum of abnormalities, referred to as Fetal Alcohol Spectrum Disorders. Physical features of the more serious Fetal Alcohol Syndrome (FAS) include smooth philtrum, thin vermillion border, short palpebral fissures, microcephaly, and growth deficiencies in weight and height. A new study has specified how specific quantities of alcohol exposure, patterns of drinking, and timing of exposure can have an impact on each of these features.

17 Jan 2012

Older adults with dementia can benefit from exergames

Virtual reality-enhanced exercise, or "exergames," combining physical exercise with computer-simulated environments and interactive videogame features, can yield a greater cognitive benefit for older adults than traditional exercise alone, according to a new study published in the February issue of the American Journal of Preventive Medicine.

17 Jan 2012

ForSight VISION4 to receive first milestone payment for Lucentis drug delivery device

Genentech, a member of the Roche Group, today announced it will make its first milestone payment to ForSight VISION4, Inc. as part of an exclusive license agreement to develop the company's investigational drug delivery device, designed to provide sustained delivery of Lucentis (ranibizumab).

13 Jan 2012

PLoS ONE journal publishes UVM team's study, Positivity of the English Language

"If it bleeds, it leads," goes the cynical saying with television and newspaper editors. In other words, most news is bad news and the worst news gets the big story on the front page. So one might expect the New York Times to contain, on average, more negative and unhappy types of words - like "war," " funeral," "cancer," "murder" - than positive, happy ones - like "love," "peace" and "hero."

13 Jan 2012

Chemotherapy drugs can lead to relapse of leukemia

The chemotherapy drugs required to push a common form of adult leukemia into remission may contribute to DNA damage that can lead to a relapse of the disease in some patients, findings of a new study suggest.

12 Jan 2012

Researchers study fusion plasmas to understand fast dynamics of networks in the human brain

Fusion plasma researchers at the University of Warwick have teamed up with Cambridge neuroscientists to apply their expertise developed to study inaccessible fusion plasmas in order to significantly improve the understanding of the data obtained from non-invasive study of the fast dynamics of networks in the human brain.

11 Jan 2012

Canadians aren't consuming sufficient fruits and vegetables, Concordia study finds

Adults from 30 to 60 years old, especially those from lower socioeconomic backgrounds, aren't consuming the daily recommended levels of fruits and vegetables. Quebecers, however, eat more of nature's produce than their fellow Canadians.

11 Jan 2012

At least two alcohol free days per week recommended

Those who drink regularly are advised to abstain from alcohol for at least two days a week. A committee of MPs has found current drinking guidelines are unclear and need to be revised. Currently the “sensible limits” for drinking, which were defined 25 years ago, are 21 units of alcohol a week for men and 14 for women. But the report by the Science and Technology Committee found many people do not know how much a unit is.

9 Jan 2012